AR051944A1 - Suspensiones farmaceuticas exentas de colorantes y metodos relacionados - Google Patents

Suspensiones farmaceuticas exentas de colorantes y metodos relacionados

Info

Publication number
AR051944A1
AR051944A1 ARP050104555A ARP050104555A AR051944A1 AR 051944 A1 AR051944 A1 AR 051944A1 AR P050104555 A ARP050104555 A AR P050104555A AR P050104555 A ARP050104555 A AR P050104555A AR 051944 A1 AR051944 A1 AR 051944A1
Authority
AR
Argentina
Prior art keywords
effective amount
related methods
exempt
colors
pharmaceutical suspensions
Prior art date
Application number
ARP050104555A
Other languages
English (en)
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of AR051944A1 publication Critical patent/AR051944A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una suspension farmacéutica exenta de colorante que posee una cantidad terapéuticamente efectiva de un primer agente activo que comprende esencialmente un primer agente activo sustancialmente insoluble en agua que posee un tamano de partícula promedio de entre aproximadamente 10 y aproximadamente 100 micrones, y una cantidad efectiva de un edulcorante no reductor; una cantidad efectiva de agua; y una cantidad efectiva de un sistema de suspension; en donde la suspension farmacéutica exenta de colorantes posee un pH de desde aproximadamente 5 hasta aproximadamente 6 y se encuentra sustancialmente exenta de azucar reductor y métodos relacionados.
ARP050104555A 2004-10-29 2005-10-31 Suspensiones farmaceuticas exentas de colorantes y metodos relacionados AR051944A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/977,655 US20060093629A1 (en) 2004-10-29 2004-10-29 Dye-free pharmaceutical suspensions and related methods

Publications (1)

Publication Number Publication Date
AR051944A1 true AR051944A1 (es) 2007-02-21

Family

ID=35871128

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104555A AR051944A1 (es) 2004-10-29 2005-10-31 Suspensiones farmaceuticas exentas de colorantes y metodos relacionados

Country Status (6)

Country Link
US (2) US20060093629A1 (es)
EP (2) EP2229937B1 (es)
CN (1) CN101065111A (es)
AR (1) AR051944A1 (es)
CA (1) CA2585855C (es)
WO (1) WO2006050101A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090028802A1 (en) * 2007-07-23 2009-01-29 Toru Hibi Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same
CN102159184B (zh) * 2008-10-09 2013-09-04 方济各安吉利克化学联合股份有限公司 含有对乙酰氨基酚的液体药物制剂
GB201103397D0 (es) * 2011-02-28 2011-04-13 Shire Movetis N V
CN110177542A (zh) * 2016-11-28 2019-08-27 强生消费者公司 包含黏膜粘着剂的液体组合物
CN108721325B (zh) * 2017-04-13 2020-03-06 辽宁大熊制药有限公司 蒙脱石混悬液及其制备方法
US20210077415A1 (en) * 2018-01-03 2021-03-18 Ferring B.V. Oral liquid pharmaceutical compositions of aminosalicylates
PE20211218A1 (es) * 2018-08-28 2021-07-05 Gsk Consumer Healthcare Sarl Suspensiones liquidas de paracetamol
CN112274483A (zh) * 2020-10-28 2021-01-29 河北冀衡药业股份有限公司 一种对乙酰氨基酚混悬滴剂及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395202A (en) * 1963-06-14 1968-07-30 American Cyanamid Co Pigment composition for marking gelating capsules
US3485719A (en) * 1967-10-13 1969-12-23 Us Agriculture Continuous process for producing xanthomonas heteropolysaccharide
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
US4427580A (en) * 1982-09-01 1984-01-24 Cornell Research Foundation, Inc. Method for separation and recovery of proteins and nucleic acids from nucleoproteins using water destructuring salts
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
GB8317696D0 (en) * 1983-06-29 1983-08-03 Shell Int Research Preparing xanthomonas heteroplysaccharide
US4892877A (en) * 1987-10-27 1990-01-09 Richardson-Vicks Inc. Antitussive liquid compositions containing phenol
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
CH678920A5 (es) * 1989-11-14 1991-11-29 Gergely Gerhard
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
EP0620001A1 (en) 1993-04-16 1994-10-19 McNEIL-PPC, INC. Aqueous pharmaceutical suspension and process for preparation thereof
JP3844491B2 (ja) * 1993-10-01 2006-11-15 シンテックス（ユー・エス・エイ）インコーポレイテッド ミコフェノール酸モフェチル高用量経口用懸濁剤
BR9505962A (pt) 1994-12-21 1997-12-23 Johnson & Johnson Suspensão farmacêutica aquosa e processo para sua preparação
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
US7300670B2 (en) * 2002-04-03 2007-11-27 Unilab Pharmatech, Ltd. Oral suspension formulation

Also Published As

Publication number Publication date
EP1809250B1 (en) 2017-01-25
US20060093629A1 (en) 2006-05-04
CA2585855C (en) 2014-04-22
EP2229937B1 (en) 2014-03-26
EP1809250A1 (en) 2007-07-25
CA2585855A1 (en) 2006-05-11
US20100226945A1 (en) 2010-09-09
EP2229937A1 (en) 2010-09-22
WO2006050101A1 (en) 2006-05-11
CN101065111A (zh) 2007-10-31

Similar Documents

Publication Publication Date Title
AR051944A1 (es) Suspensiones farmaceuticas exentas de colorantes y metodos relacionados
AR051411A1 (es) Suspensiones farmaceuticas exentas de colorantes y metodos relacionados
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
NZ709754A (en) Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
CU23440B7 (es) Composición de liberación sostenida de pramipexol
CA2379605A1 (en) Topical suspension formulations containing ciprofloxacin and dexamethasone
EA200500909A1 (ru) Модифицированное высвобождение фармацевтической композиции
DK1553927T3 (da) Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger
WO2007019232A3 (en) Immunoconjugate formulations
MY140676A (en) Structured body wash
AR032503A1 (es) Composicion liquida
ES2393973T1 (es) Sistemas espesados con tensioactivos que comprenden celulosa microfibrosa y métodos para su fabricación
AR078161A1 (es) Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
ATE258432T1 (de) Geschmacksmaskierte flüssige suspensionen
ATE386506T1 (de) Verabreichung unlöslicher arzneistoffe
ECSP044974A (es) Formulación de suspensión oral estabilizada
HUP0302311A2 (hu) Gyógyászati aeroszol-készítmények
AR043272A1 (es) Una microparticula recubierta con una sustancia lipofilica que contiene una droga proteica o antigeno y formulaciones que la comprenden
AR061351A1 (es) Composicion de carbamato de bencimidazol
AR051412A1 (es) Suspensiones farmaceuticas exentas de colorantes y metodods relacionados
DK2018153T3 (da) Flydende orale sammensætninger
GT200200015A (es) Formulacion agroquimica
NO20076108L (no) Gelatin-inneholdende topikal sammensetning
JP2004538297A5 (es)
CO4410174A1 (es) Preparaciones farmaceuticas de cefixima

Legal Events

Date Code Title Description
FB Suspension of granting procedure